Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Putney

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Nature|February 20, 1992
Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibodyE A Emini, W A Schleif, J H Nunberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1997
In vivo characterization of sustained-release formulations of human growth hormoneH J Lee, G Riley, O Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope proteinK Javaherian, A J Langlois, C McDanal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1991
Priming with T helper cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV-1 in primatesA Hosmalin, P L Nara, M Zweig, et al.
Pharmaceutical Research|June 1, 1997
The stabilization and encapsulation of human growth hormone into biodegradable microspheresO L Johnson, W Jaworowicz, J L Cleland, et al.
Science (New York, N.Y.)|December 12, 1986
HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelopeS D Putney, T J Matthews, W G Robey, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Nature|February 20, 1992
Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibodyE A Emini, W A Schleif, J H Nunberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1997
In vivo characterization of sustained-release formulations of human growth hormoneH J Lee, G Riley, O Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope proteinK Javaherian, A J Langlois, C McDanal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1991
Priming with T helper cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV-1 in primatesA Hosmalin, P L Nara, M Zweig, et al.
Pharmaceutical Research|June 1, 1997
The stabilization and encapsulation of human growth hormone into biodegradable microspheresO L Johnson, W Jaworowicz, J L Cleland, et al.
Science (New York, N.Y.)|December 12, 1986
HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelopeS D Putney, T J Matthews, W G Robey, et al.
Pageof 5